V CompBrief BY VELARION

Chief Financial Officer · Perspective Therapeutics, Inc. (CATX)

Joel Sendek

FY2025 is the first fiscal year CompBrief holds for Joel Sendek as a named executive officer of Perspective Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$1,986,552

3rd of 4 named executive officers at Perspective Therapeutics by FY2025 total.

4 named officers on file for Perspective Therapeutics, FY2025

See an example →

What this number hides

The filing gives the total. Perspective Therapeutics’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Perspective Therapeutics’s whole pay program stands against its peers

  • Perspective Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CATX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 16, 2026 (DEF 14A).

Free

Get Joel Sendek’s full pay file as a PDF — free

More than this page: up to 10 years of Joel’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Joel Sendek and every company like it: Velarion Intel, free for 3 days, no card →

Joel Sendek compensation by year

Perspective Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Perspective Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$163,014
Bonus$0
Stock awards$0
Option awards$1,750,838
Non-equity incentive$65,200
Pension and deferred compensation$0
All other$7,500
Total$1,986,552

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Perspective Therapeutics, Inc. DEF 14A filed April 16, 2026, accession 0001193125-26-159005, and prior-year filings.

How this page was built: the Perspective Therapeutics, Inc. filed document, accession 0001193125-26-159005. Every figure is read from that document and cited to the page and table it appears in. Filed April 16, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option600,000—$3.54

Per the Outstanding Equity Awards at Fiscal Year-End table in Perspective Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Perspective Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Johan SpoorChief Executive Officer, Director$2,404,692
Juan GrahamFormer Chief Financial Officer$2,234,930
Joel Sendek · this pageChief Financial Officer$1,986,552
Markus PuhlmannChief Medical Officer$1,068,083

Joel Sendek's compensation dossier, Perspective Therapeutics

You have read Joel Sendek's totals and holdings. The dossier adds each equity grant Perspective Therapeutics disclosed for Joel Sendek and Perspective Therapeutics's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Perspective Therapeutics compensation record

free company brief
Perspective Therapeutics, Inc. (CATX) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within Perspective Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Perspective Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Perspective Therapeutics's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosures
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Perspective Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Joel Sendek's compensation dossier